A previous report by Suzuki et al. indicated an increased proportion of the CD14++CD16+ intermediate monocyte subset in AF subjects compared to that of healthy control subjects [27], while our flow cytometric analysis showed no difference in the proportions of intermediate monocytes between non-AF and AF participants. The gene discussed is CD14; the disease is atrial fibrillation.